New hemophilia drug enters human safety trials

NCT ID NCT06349473

Recruiting now Disease control Sponsor: Equilibra Bioscience LLC Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jul 02, 2026 · Updated 1 time

Summary

This early-stage study tests a new drug called SR604 in healthy people and those with hemophilia A, B, or factor VII deficiency. The main goal is to check safety and how the drug moves through the body. About 31 participants will receive single or multiple doses to find the right amount for future studies.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for FACTOR VII DEFICIENCY are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

factor VII deficiency hemophilia A hemophilia B

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

FACTOR VII DEFICIENCY HEALTHY PARTICIPANTS HEMOPHILIA A HEMOPHILIA B

Contacts and locations

Locations

Brody School of Medicine at East Carolina University
NOT_YET_RECRUITING

Greenville, North Carolina, 27834, United States
California Clinical Trials Medical Group (CCTMG)
COMPLETED

Glendale, California, 91206, United States
Children's Hospital Los Angeles
RECRUITING

Los Angeles, California, 90027, United States
LA Center for Bleeding and Clotting Disorders - Metairie
RECRUITING

Metairie, Louisiana, 70001, United States
McMaster University Medical Centre, Hamilton Health Sciences
RECRUITING

Hamilton, Ontario, L8N 3Z5, Canada
Penn State Milton S Hershey Medical Center Pediatrics
RECRUITING

Hershey, Pennsylvania, 17033, United States
Perelman Center for Advanced Medicine (PCAM)- Penn Blood Disorders Program
RECRUITING

Philadelphia, Pennsylvania, 19104, United States
Rush University Medical Center
RECRUITING

Chicago, Illinois, 60612, United States
University of Michigan Hospitals - Michigan Medicine
RECRUITING

Ann Arbor, Michigan, 48109, United States
Washington University School of Medicine
RECRUITING

St Louis, Missouri, 63110, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.